106 related articles for article (PubMed ID: 9625258)
1. Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo.
White SJ; Page SM; Margaritis P; Brownlee GG
Hum Gene Ther; 1998 May; 9(8):1187-95. PubMed ID: 9625258
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-specific enhancer activity in transduced keratinocytes: a model for epidermal gene therapy.
Page SM; Brownlee GG
Gene Ther; 1998 Mar; 5(3):394-402. PubMed ID: 9614560
[TBL] [Abstract][Full Text] [Related]
3. An ex vivo keratinocyte model for gene therapy of hemophilia B.
Page SM; Brownlee GG
J Invest Dermatol; 1997 Aug; 109(2):139-45. PubMed ID: 9242498
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of a retrovirus-transduced gene in human keratinocytes.
Fenjves ES; Yao SN; Kurachi K; Taichman LB
J Invest Dermatol; 1996 Mar; 106(3):576-8. PubMed ID: 8648197
[TBL] [Abstract][Full Text] [Related]
5. Towards gene therapy for haemophilia B using primary human keratinocytes.
Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
[TBL] [Abstract][Full Text] [Related]
6. Optimised retroviral infection of human epidermal keratinocytes: long-term expression of transduced integrin gene following grafting on to SCID mice.
Levy L; Broad S; Zhu AJ; Carroll JM; Khazaal I; Péault B; Watt FM
Gene Ther; 1998 Jul; 5(7):913-22. PubMed ID: 9813662
[TBL] [Abstract][Full Text] [Related]
7. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
[TBL] [Abstract][Full Text] [Related]
8. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
Yao SN; Smith KJ; Kurachi K
Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
[TBL] [Abstract][Full Text] [Related]
9. Expression of biologically active human factor IX in human hematopoietic cells after retroviral vector-mediated gene transduction.
Hao QL; Malik P; Salazar R; Tang H; Gordon EM; Kohn DB
Hum Gene Ther; 1995 Jul; 6(7):873-80. PubMed ID: 7578406
[TBL] [Abstract][Full Text] [Related]
10. Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA.
Matsushita T; Emi N; Takahashi I; Takamatsu J; Saito H
Thromb Res; 1993 Feb; 69(4):387-93. PubMed ID: 8470060
[TBL] [Abstract][Full Text] [Related]
11. Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo.
Pfützner W; Vogel JC
Cells Tissues Organs; 2004; 177(3):151-9. PubMed ID: 15388989
[TBL] [Abstract][Full Text] [Related]
12. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
13. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
14. A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.
Serrano F; Del Rio M; Larcher F; Garcia M; Muñoz E; Escamez MJ; Muñoz M; Meana A; Bernad A; Jorcano JL
Hum Gene Ther; 2003 Nov; 14(16):1579-85. PubMed ID: 14577919
[TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.
Kuhn U; Terunuma A; Pfutzner W; Foster RA; Vogel JC
J Virol; 2002 Feb; 76(3):1496-504. PubMed ID: 11773422
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.
Stockschläder MA; Schuening FG; Graham TC; Storb R
Gene Ther; 1994 Sep; 1(5):317-22. PubMed ID: 7584097
[TBL] [Abstract][Full Text] [Related]
17. Successful culture and sustainability in vivo of gene-modified human oral mucosal epithelium.
Mizuno H; Emi N; Abe A; Takahashi I; Kojima T; Saito H; Sumi Y; Hata KI; Ueda M
Hum Gene Ther; 1999 Mar; 10(5):825-30. PubMed ID: 10210149
[TBL] [Abstract][Full Text] [Related]
18. Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells.
Murray L; Travis M; Luens-Abitorabi K; Olsson K; Plavec I; Forestell S; Hanania EG; Hill B
Hum Gene Ther; 2000 Sep; 11(14):2039-50. PubMed ID: 11020802
[TBL] [Abstract][Full Text] [Related]
19. Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents.
Brauker J; Frost GH; Dwarki V; Nijjar T; Chin R; Carr-Brendel V; Jasunas C; Hodgett D; Stone W; Cohen LK; Johnson RC
Hum Gene Ther; 1998 Apr; 9(6):879-88. PubMed ID: 9581910
[TBL] [Abstract][Full Text] [Related]
20. Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.
Fehse B; Uhde A; Fehse N; Eckert HG; Clausen J; Rüger R; Koch S; Ostertag W; Zander AR; Stockschläder M
Hum Gene Ther; 1997 Oct; 8(15):1815-24. PubMed ID: 9358031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
